72.11.Z - Research and experimental development on biotechnology
20.1 - Manufacture of basic chemicals, fertilisers and nitrogen compounds, plastics and synthetic rubber in primary forms
20.20.Z - Manufacture of pesticides and other agrochemical products
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
62.09.Z - Other information technology and computer service activities
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -16,4 | -20,2 | -26 | -29 |
EBITDA | -14,4 | -18,4 | -22,1 | -20,5 |
Short time liabilities | 3,2 | 3,9 | 5,4 | 39,4 |
Equity capital | 13,7 | 55,7 | 44,1 | -20,9 |
Operating profit (EBIT) | -16,1 | -20,3 | -26,5 | -30,7 |
Assets | 33,1 | 70,5 | 62,9 | -10,8 |
Net profit (loss) | -16,4 | -20,2 | -26 | -29 |
Cash | 9,6 | 38 | 16,4 | -56,8 |
Liabilities and provisions for liabilities | 19,4 | 14,8 | 18,8 | 27,2 |
Net income from sale | 3,2 | 2,7 | 3 | 8,5 |
Working assets | 13,3 | 41,8 | 22,8 | -45,5 |
Depreciation | 1,7 | 1,9 | 4,4 | 129,3 |
% | % | % | p.p. | |
Profitability of capital | -120 | -36,2 | -59 | -22,8 |
Equity capital to total assets | 41,3 | 79 | 70,1 | -8,9 |
Gross profit margin | -512,7 | -739,3 | -878,8 | -139,5 |
EBITDA Margin | -448,5 | -672,9 | -747,1 | -74,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 360 | 519 | 667 | 148 |
Current financial liquidity indicator | 1.220201849937439 | 3.423384189605713 | 1.42479407787323 | -2 |
Net dept to EBITDA | 0.11541309207677841 | 1.995145559310913 | 0.6316723823547363 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane